SHE:002317 Market Cap

SHE:002317 has a market cap or net worth of 18.56 billion as of June 9, 2026. Its market cap has increased by 83.15% in one year.

Market Cap

18.56B

Enterprise Value

17.44B

Revenue

2.51B

Ranking

n/a

PE Ratio

62.40

Stock Price

21.84

Market Cap Chart

Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 18.56B, an increase of 157.27%. That is a compound annual growth rate of 5.89%.

Market Cap History

Date	Market Cap	% Change
Jun 8, 2026	18.54B	14.91%
Dec 31, 2025	16.13B	56.94%
Dec 31, 2024	10.28B	-24.46%
Dec 29, 2023	13.61B	-37.64%
Dec 30, 2022	21.82B	126.34%
Dec 31, 2021	9.64B	8.90%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Betta Pharmaceuticals	20.57B
Jilin Aodong Pharmaceutical Group	19.90B
Chengdu Kanghong Pharmaceutical Group	19.65B
Jiangsu Nhwa Pharmaceutical Co., LTD	19.62B
Hybio Pharmaceutical	18.96B
Walvax Biotechnology	18.92B
Dizal (Jiangsu) Pharmaceutical	18.37B
Apeloa Pharmaceutical Co.,Ltd	18.16B

Market Cap Rankings